Michael Flemmens, a scientist with over 25 years
of product development, sales, and technical support experience, drives key research initiatives and provides strategic leadership in the application and commercialization of SōRSE’s technology platforms.
Prior to SōRSE, he served as Director of Corporate
Technology Development for Secant Group, LLC,
a leader in next-generation biomaterials, structures,
and medical textiles that enable restoration of
the human body.
Michael Flemmens
Michael has worked on a patented new cancer treatment,
had a Type IV Drug Master File approved by the FDA, and
received JECFA approval for a new food ingredient. He also
designed the build-out of seven novel manufacturing lines
and has held multiple government contracts
for novel security products.
Related Leaders
Howard Lee
Scott Riefler
Tim O’Neill
Hilary Brown
